1. Home
  2. SCLX vs DUOT Comparison

SCLX vs DUOT Comparison

Compare SCLX & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • DUOT
  • Stock Information
  • Founded
  • SCLX 2011
  • DUOT 1990
  • Country
  • SCLX United States
  • DUOT United States
  • Employees
  • SCLX N/A
  • DUOT N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • SCLX Health Care
  • DUOT Technology
  • Exchange
  • SCLX Nasdaq
  • DUOT Nasdaq
  • Market Cap
  • SCLX 61.5M
  • DUOT 66.3M
  • IPO Year
  • SCLX N/A
  • DUOT N/A
  • Fundamental
  • Price
  • SCLX $0.33
  • DUOT $6.83
  • Analyst Decision
  • SCLX Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • SCLX 4
  • DUOT 2
  • Target Price
  • SCLX $14.00
  • DUOT $10.75
  • AVG Volume (30 Days)
  • SCLX 184.3K
  • DUOT 151.3K
  • Earning Date
  • SCLX 03-11-2025
  • DUOT 03-31-2025
  • Dividend Yield
  • SCLX N/A
  • DUOT N/A
  • EPS Growth
  • SCLX N/A
  • DUOT N/A
  • EPS
  • SCLX N/A
  • DUOT N/A
  • Revenue
  • SCLX $55,152,000.00
  • DUOT $7,346,014.00
  • Revenue This Year
  • SCLX $24.19
  • DUOT $16.88
  • Revenue Next Year
  • SCLX $109.90
  • DUOT $183.85
  • P/E Ratio
  • SCLX N/A
  • DUOT N/A
  • Revenue Growth
  • SCLX 22.02
  • DUOT N/A
  • 52 Week Low
  • SCLX $0.32
  • DUOT $2.03
  • 52 Week High
  • SCLX $2.63
  • DUOT $8.53
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 30.09
  • DUOT 52.05
  • Support Level
  • SCLX $0.33
  • DUOT $6.30
  • Resistance Level
  • SCLX $0.36
  • DUOT $7.63
  • Average True Range (ATR)
  • SCLX 0.03
  • DUOT 0.82
  • MACD
  • SCLX -0.00
  • DUOT -0.06
  • Stochastic Oscillator
  • SCLX 8.90
  • DUOT 57.51

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: